Hereditary breast cancer

British Journal of Surgery

Volumn 84, Issue 10, 1997, Pages 1334-1339

  Hill, A D K ^a   Doyle, J M ^a   McDermott, E W ^a   O'Higgins, N J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETICS; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

BREAST NEOPLASMS; FEMALE; FORECASTING; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION;

EID: 0030843288     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800841004     Document Type: Review

References (66)

1. O'Miggins N. Aspects of breast cancers. Chirurgie 1992; 118: 324-7.
2. McKinlcy AG, Russell SEH, Spcnce RAJ, Odling-Smee W, Ncvin NC. Hereditary breast cancer and linkage analysis to RRCAl. BrJSurg 1995; 82: 1086-8.
3. Lynch HT, Lynch J, Comvay T et al. Hereditary breast cancer and family cancer syndromes. World J Surg 1994; 18: 21-31.
4. Winchester DP. Putting prophylactic mastectomy in proper perspective. CA Cancer J Clin 1995; 45: 261-2 (Editorial).
5. Lynch HT, Watson P, Conway TA, Lynch JF. Natural history and ace at onset of hereditary breast cancer. Cancer 1992; 69: 1404-~7.
6. Black DM. The genetics of breast cancer. EurJ Cancer 1994; 30A: 1957-61.
7. Miki Y, Swcnsen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
8. FitzGerald MG, MacDonald DJ, Krainer M et al. Germ-line mutations in Jewish and non-Jewish women with early-onset breast cancer. N EnglJ Med 1996; 334: 143-9.
9. Anderson DE. Familial versus sporadic breast cancer. Cancer 1992; 70(Suppl): 1740-6.
10. Hall JM, Lee MK, Newman B et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 1990; 250: 1684-9.
11. Narod SA, Feunteun J, Lynch HT et al. Familial breastovarian cancer locus on chromosome 17ql2-q23. Lancet 1991; 338: 82-3.
12. Futreal PA, Liu Q, Shattuck-Eidens D et al. RRCAl mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-2.
13. Easton DF, Narod SA, Ford D. Steel M. The genetic epidemiolosy of RRCAl. Breast Cancer Linkaee Consortium. Lancet 1994; 344: 761 (Letter).
14. Bishop DT. RRCAl, BRCA2, RRCA3 ... a myriad of breast cancer genes. EurJ Cancer 1994; 30A: 1738-9.
15. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrandcr EA. RRCAl mutations in a population-based sample of young women with breast cancer. TV Eng! J Med 1996; 334: 137-42.
16. Collins FS. BRCA1 - lots of mutations, lots of dilemmas. N EnglJ Med 1996; 334: 186-8 (Editorial).
17. Chen Y, Chen CF, Rilcy DJ et al. Aberrant subcellular localization of RRCAl in breast cancer. Science 1995; 270: 789-91.
18. Davies K. Breast cancer genes. Further eniematic variations. Nature 1995; 378: 762-3.
19. Nowak R. Breast cancer gene offers surprises. Science 1994; 265: 1796-9.
20. Bieseckcr BB, Boehnke M, Calzone K et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269: 1970-4.
21. Weber BL, Abel KJ, Brody LC et al. Familial breast cancer. Approaching the isolation of a susceptibility gene. Cancer 1994; 74(Suppl): 1013-20.
22. Easton DF, Bishop DT, Ford D, Crockford GP. Breast Cancer Linkage Consortium: genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52; 678-701.
23. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE and the Breast Cancer Linkage Consortium. Risks of cancer in BRCA/-mutation carriers. Lancet 1994; 343: 692-5.
24. Hoskins KF, Stopfer JE, Calzone KA et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995; 273: 577-85.
25. Radford DM, Zehnbauer BA. Inherited breast cancer. Surg Clin North Am 1996; 76: 205-20.
26. Easton DF. The inherited component of cancer. Rr Med Bull 1994; 50: 527-35.
27. Birch JM, Hartley AL, Ticker KJ et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54: 1298-304.
28. Woostcr R, Neuhauscn SL, Mangion J et al. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13ql2-13. Science 1994; 265: 2088-90.
29. Narod SA, Ford D, Devilee P et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkace Consortium. Am J Hum Genet 1995; 56: 254-64.
30. Simard J, Tonin P, Durocher F et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994; 8: 392-8.
31. Gayther SA, Waren W, Mazoyer S et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995; 11: 428-33.
32. Struewing JP, Brody LC, Erdos MR et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995; 57: Ir7.
33. Gao X, Zacharek A, Salkowski A et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995; 55: 1002-5.
34. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
35. Li FP, Fraumeni JF Jr. Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969; 71: 747-52.
36. Birch JM. Li-Fraumeni syndrome. Ettr J Cancer 1994; 30A: 1935-41.
37. Evans DG, Fentiman IS, McPherson K, Asbury D, Ponder BA, Howell A. Familial breast cancer. BMJ 1994; 308: 183-7]
38. Easton D, Ford D, Peto J. Inherited susceptibility to breast cancer. Cancer Sun' 1993; 18: 95-113.
39. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxic-telangiectasia. NEnglJMed 1991;325: 1831-6.
40. Savitsky K, Bar-Shira A, Gilad S et al. A single ataxia telangiectasia gene with a product similar to Pl-3 kinase. Science 1995; 268: 1749-53.
41. Nowak R. Discovery of AT gene sparks biomédical research bonanza. Science 1995; 268: 1700-1.
42. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 1289-94.
43. Lobaccaro JM, Lumbroso S, Belon C et al. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993; 2: 1799-802.
44. Lindblom A, Skoog L, Rotstein S, Werelius B, Larsson C, Nordenskjold M. Loss of heterozygosity in familial breast carcinomas. Cancer Res 1993; 53: 4356-61.
45. Nelen MR, Padberg GW, Pceters EA et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13: 114-16.
46. Hahn H, Wicking C, Zaphiropoulos PG et al. Mutations of the human homolog of Drosopliila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-51.
47. Porter DE, Steel CM, Cohen BB et al. Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals. BrJSurg 1993; 80: 1381-5.
48. Porter DE, Cohen BB, Wallace MR et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17ql2-21. BrJSurg 1994; 81: 1512-15.
49. Shattuck-Eidens D, McClure M, Simard J et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995; 273: 535-41.
50. Lynch HT, Severin MJ, Mooney MJ, Lynch J. Insurance adjudication favouring prophylactic surgery in hereditary breast-ovarian cancer syndrome. Gynccol Oncol 1995; 57: 23-6.
51. Bilimoria MM, Morrow M. The woman at increased risk of breast cancer: evaluation and management strategies. CA Cancer J Clin 1995; 45: 263-78.
52. Decker D. Prophylactic mastectomy for familial breast cancer. JAMA 1993; 269: 2608-9.
53. Morrow M. Identification and management of women at increased risk of breast cancer development. Breast Cancer ' Res Treat 1994; 31: 53-60.
54. Eldar S, Meguid MM, Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 1984; 148: 692-3.
55. Holleb AI, Montgomery R, Farrow JH et al. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet 1965; 121: 819-22.
56. Wapnir IL, Rabinowitz B, Greco RS. A reappraisal of prophylactic mastectomy. Surg Gynecol Obstet 1990; 171: 171-84.
57. Nease RF Jr, Ross JM. The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs. Am J Med 1995; 99: 108-9.
58. Powles TJ, Tillyer CR, Jones AL et al. Prevention of breast cancer with tamoxifen - an update on the Royal Marsden Hospital pilot programme. EurJ Cancer 1990; 26: 680-4.
59. Greenwald P, Kelloff G, Burch-Whitman C, Kramer BS. Chemoprevention. CA Cancer J Clin 1995; 45: 31-49.
60. Fornander T, Rutqvist LE, Cedermark B et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989; i: 117-20.
61. Hortobagyi GN, Buzdar AU. Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy. CA Cancer J Clin 1995; 45: 199-226.
62. Love RR. Tamoxifen prophylaxis in breast cancer. Oncology 1992; 6: 33-8.
63. Love RR. Prevention of breast cancer in premenopausal women. J Natl Cancer Inst (Monogr) 1994; 16: 61-5.
64. Austoker J. Screening for breast cancer: psychosocial issues. Oncology 1995; 23: 438-40.
65. Austoker J. Screening and self examination for breast cancer. BMJ 1994; 309: 168-74.
66. Meyer JE, Kopans DB, Oot R. Breast cancer visualized by marhmography in patients under 35. Radiology 1983; 147: 93-4.